In this case the turd has been sugared, the pill polished but make no mistake, Midatech Pharma (MTPH) is well in the merde and that is bad news for Britain’s most conceited fund manager Neil Woodford whose funds own 20% of the equity.
on ShareProphets | CommentsFiled under: